Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Next-Generation Sequencing Based Monitoring of Circulating-Tumor DNA in Untreated Peripheral T-Cell Lymphoma

Christopher Melani, MD, Stefania Pittaluga, MD PhD, Lydia Yee, CRNP, Andrea Lucas, RN, Margaret Shovlin, RN, Allison Jacob, MS, Kenneth Chan, PhD, Marissa Vignali, PhD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD PhD, Mark Roschewski, MD

Blood (2017) 130 (Supplement 1): 2728.

https://doi.org/10.1182/blood.V130.Suppl_1.2728.2728

Published: 2017

Journal Articles

End-of-Treatment CT and Serial FDG-PET Imaging to Assess Residual Disease in Primary Mediastinal B-Cell Lymphoma

Christopher Melani, MD, Ranjana H. Advani, MD, Mark Roschewski, MD, Kelsey M. Walters, BS, Clara C. Chen, MD, Lucia Barrato, MD, Mark A. Ahlman, MD, Milos D. Miljkovic, MD, Seth M. Steinberg, PhD, Margaret Shovlin, RN, Kieron Dunleavy, MD, Stefania Pittaluga, MD PhD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD PhD

Blood (2017) 130 (Supplement 1): 2859.

https://doi.org/10.1182/blood.V130.Suppl_1.2859.2859

Published: 2017

Journal Articles

Quantitative Baseline Circulating Tumor DNA Levels Correlate with GM-CSF Response to Idiotype Vaccine in Untreated Mantle Cell Lymphoma

Mark Roschewski, MD, Kieron Dunleavy, MD, Sattva S. Neelapu, MD, Stefania Pittaluga, MD PhD, Christopher Joseph Melani, MD, Elaine S. Jaffe, MD, Margaret Shovlin, RN, Beryl Crossley, BS, Katie Kong, BS, Allison Jacob, MD, Larry Kwak, Wyndham H. Wilson, MD PhD

Blood (2016) 128 (22): 2943.

https://doi.org/10.1182/blood.V128.22.2943.2943

Published: 2016

Journal Articles

DA-EPOCH-R in Primary Mediastinal B-Cell Lymphoma; Analysis of End of Therapy FDG-PET and Outcome

Christopher Joseph Melani, MD, Ranjana Advani, MD, Clara C. Chen, MD, Kelsey M. Walters, BS, David Venzon, PhD, Seth M. Steinberg, PhD, Margaret Shovlin, RN, Elaine S. Jaffe, MD, Stefania Pittaluga, MD PhD, Mark Roschewski, MD, Wyndham H. Wilson, MD PhD, Kieron Dunleavy, MD

Blood (2016) 128 (22): 1116.

https://doi.org/10.1182/blood.V128.22.1116.1116

Published: 2016

Journal Articles

Monitoring of Circulating Tumor DNA As Minimal Residual Disease in Diffuse Large B-Cell Lymphoma

Mark Roschewski, MD, Kieron Dunleavy, MD, Stefania Pittaluga, Katie Kong, Margaret Shovlin, RN, Elaine S. Jaffe, Louis M. Staudt, MD PhD, Catherine Lai, MD MPH, Clara C. Chen, MD, Jianbiao Zheng, PhD, Thomas D. Willis, PhD, Malek Faham, Wyndham H Wilson, MD PhD

Blood (2014) 124 (21): 139.

https://doi.org/10.1182/blood.V124.21.139.139

Published: 2014

Journal Articles

A prospective study of mediastinal gray-zone lymphoma

Wyndham H. Wilson, Stefania Pittaluga, Alina Nicolae, Kevin Camphausen, Margaret Shovlin, Seth M. Steinberg, Mark Roschewski, Louis M. Staudt, Elaine S. Jaffe, Kieron Dunleavy

Blood (2014) 124 (10): 1563–1569.

https://doi.org/10.1182/blood-2014-03-564906

Published: 2014

Journal Articles

Concurrent Expression Of MYC/BCL2 Protein In Newly Diagnosed DLBCL Is Not Associated With An Inferior Survival Following EPOCH-R Therapy

Kieron Dunleavy, MD, Stefania Pittaluga, MD, Margaret Shovlin, RN, Svetlana Pack, Seth M. Steinberg, PhD, Catherine E. Lai, MD, Cliona Grant, MD, Eric D. Hsi, MD, Louis M. Staudt, MD, PhD, Elaine S. Jaffe, MD, Wyndham H Wilson, MD, PhD

Blood (2013) 122 (21): 3029.

https://doi.org/10.1182/blood.V122.21.3029.3029

Published: 2013

Journal Articles

DNA Sequencing-Based Monitoring Of Serum Predicts Clinical Relapse Before CT Imaging in Diffuse Large B-Cell Lymphoma

Mark Roschewski, MD, Stefania Pittaluga, MD, Kieron Dunleavy, MD, Katherine Kong, MS, Margaret Shovlin, RN, Elaine S. Jaffe, MD, Louis M. Staudt, MD, PhD, Jianbiao Zheng, PhD, Tom Willis, PhD, Malek Faham, MD, PhD, Wyndham H Wilson, MD, PhD

Blood (2013) 122 (21): 1767.

https://doi.org/10.1182/blood.V122.21.1767.1767

Published: 2013

Journal Articles

Study On The Fertility Status Of Females With Primary Mediastinal B-Cell Lymphoma Following Treatment With Dose-Adjusted EPOCH-Rituximab

Helen Gharwan, MD, DSc, Kieron Dunleavy, MD, Margaret Shovlin, RN, Antonio T Fojo, MD, PhD, Thomas A. Fleisher, MD, Wyndham H Wilson, MD, PhD, Cliona Grant, MD

Blood (2013) 122 (21): 1779.

https://doi.org/10.1182/blood.V122.21.1779.1779

Published: 2013

Journal Articles

DA-EPOCH Chemotherapy Is Highly Effective in ALK-Positive and ALK-Negative ALCL: Results of a Prospective Study of PTCL Subtypes in Adults

Kieron Dunleavy, MD, Margaret Shovlin, RN, Stefania Pittaluga, MD, Cliona Grant, MD, Seth M. Steinberg, PhD, Elaine S. Jaffe, MD, Wyndham H Wilson, MD, PhD

Blood (2011) 118 (21): 1618.

https://doi.org/10.1182/blood.V118.21.1618.1618

Published: 2011

Journal Articles

Rituximab Is Associated with Prolonged Immunoglobulin Deficiency In Newly Diagnosed Patients with Aggressive B-Cell Lymphoma Receiving Immunochemotherapy

Kieron Dunleavy, MD, Benjamin L.W. Reiter, Cliona M. Grant, MD, Margaret Shovlin, RN, George W. Wright, Thomas A. Fleisher, MD, Wyndham H. Wilson, MD, PhD

Blood (2010) 116 (21): 2881.

https://doi.org/10.1182/blood.V116.21.2881.2881

Published: 2010

Journal Articles

Comparative Clinical and Biological Features of Primary Mediastinal B-Cell Lymphoma (PMBL) and Mediastinal Grey Zone Lymphoma (MGZL).

Kieron Dunleavy, MD, Stefania Pittaluga, MD, Kevin Tay, MD, Nicole Grant, MPH, Clara C Chen, MD, Margaret Shovlin, RN, Seth Steinberg, PhD, Louis M Staudt, MD, PhD, Elaine S Jaffe, MD, John E Janik, MD, Wyndham H Wilson, MD, PhD

Blood (2009) 114 (22): 106.

https://doi.org/10.1182/blood.V114.22.106.106

Published: 2009

Journal Articles

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

Kieron Dunleavy, Stefania Pittaluga, Myron S. Czuczman, Sandeep S. Dave, George Wright, Nicole Grant, Margaret Shovlin, Elaine S. Jaffe, John E. Janik, Louis M. Staudt, Wyndham H. Wilson

Blood (2009) 113 (24): 6069–6076.

https://doi.org/10.1182/blood-2009-01-199679

Published: 2009

Journal Articles

Gray Zone Lymphomas: Clinical and Histological Characteristics and Treatment with Dose-Adjusted-EPOCH-R

Kieron Dunleavy, MD, Stefania Pittaluga, MD, PhD, Nicole Grant, MPH, Seth Steinberg, PhD, Margaret Shovlin, RN, Kevin Tay, MD, John E. Janik, MD, Elaine S. Jaffe, M.D., Wyndham H. Wilson, MD, PhD

Blood (2008) 112 (11): 3590.

https://doi.org/10.1182/blood.V112.11.3590.3590

Published: 2008

Journal Articles

A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Refractory or Relapsed Lymphoid Malignancies.

Wyndham H. Wilson, Anil Tulpule, Alexandra M. Levine, Kieron Dunleavy, Andrew P. Krivoshik, Anne E. Hagey, Margaret Shovlin, Melanie A. Gloria, Renee Greco, Hao Xiong, Yi-Lin Chiu, Steven W. Elmore, Owen A. O’Connor

Blood (2007) 110 (11): 1371.

https://doi.org/10.1182/blood.V110.11.1371.1371

Published: 2007

Journal Articles

Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome May Be Significantly Improved by the Addition of Rituximab to Dose-Adjusted (DA)-EPOCH and Obviates the Need for Radiation: Results from a Prospective Study of 44 Patients.

Kieron Dunleavy, MD, Stefania Pittaluga, MD, John Janik, MD, Nicole Grant, MPH, Margaret Shovlin, RN, Seth Steinberg, PhD, Mark Raffeld, MD, Louis Staudt, MD, PhD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD, PhD

Blood (2006) 108 (11): 209.

https://doi.org/10.1182/blood.V108.11.209.209

Published: 2006

Journal Articles

DA-EPOCH-R Is Highly Effective in Both BCL-6+ and BCL-6− Untreated De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Study Update and Analysis of Survival Outcomes for Multiple Biomarkers.

Wyndham H. Wilson, MD, PhD, Kieron Dunleavy, MD, Stefania Pittaluga, MD, Nicole Grant, MPH, Margaret Shovlin, RN, Seth Steinberg, PhD, Mark Raffeld, MD, Louis Staudt, MD, PhD, Elaine S. Jaffe, MD, John Janik, MD

Blood (2006) 108 (11): 206.

https://doi.org/10.1182/blood.V108.11.206.206

Published: 2006

Journal Articles

Novel Treatment of Burkitt Lymphoma with Dose-Adjusted EPOCH-Rituximab: Preliminary Results Showing Excellent Outcome.

Kieron Dunleavy, MD, Stefania Pittaluga, MD, John Janik, MD, Nicole Grant, MPH, Margaret Shovlin, RN, Richard Little, MD, Robert Yarchoan, MD, Seth Steinberg, PhD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD, PhD

Blood (2006) 108 (11): 2736.

https://doi.org/10.1182/blood.V108.11.2736.2736

Published: 2006

Journal Articles

A Pilot Trial of Campath-1H and Dose-Adjusted EPOCH in CD52-Expressing Aggressive T-Cell Malignancies.

John E. Janik, MD, Kieron Dunleavy, MD, Stefania Pittaluga, MD, Elaine S. Jaffe, MD, Nicole Grant, MPH, Margaret Shovlin, Maryalice Stetler-Stevenson, MD, Wyndham H. Wilson, MD

Blood (2005) 106 (11): 3348.

https://doi.org/10.1182/blood.V106.11.3348.3348

Published: 2005

Journal Articles

Phase I/II study of Bortezomib Alone and Bortezomib with Dose-Adjusted EPOCH Chemotherapy in Relapsed or Refractory Aggressive B-Cell Lymphoma.

Kieron Dunleavy, M.D., John Janik, M.D., Juan Gea-Banacloche, M.D., Margaret Shovlin, B.S.N., Therese White, M.S.N., Neta Goldschmidt, M.D., Nicole Grant, M.P.H., Omer Koc, M.D., Stefania Pittaluga, M.D., Elaine Jaffe, M.D., Louis Staudt, M.D., Ph.D., Wyndham H. Wilson, M.D., Ph.D.

Blood (2004) 104 (11): 1385.

https://doi.org/10.1182/blood.V104.11.1385.1385

Published: 2004

NARROW

Next-Generation Sequencing Based Monitoring of Circulating-Tumor DNA in Untreated Peripheral T-Cell Lymphoma

End-of-Treatment CT and Serial FDG-PET Imaging to Assess Residual Disease in Primary Mediastinal B-Cell Lymphoma

Quantitative Baseline Circulating Tumor DNA Levels Correlate with GM-CSF Response to Idiotype Vaccine in Untreated Mantle Cell Lymphoma

DA-EPOCH-R in Primary Mediastinal B-Cell Lymphoma; Analysis of End of Therapy FDG-PET and Outcome

Monitoring of Circulating Tumor DNA As Minimal Residual Disease in Diffuse Large B-Cell Lymphoma

A prospective study of mediastinal gray-zone lymphoma

Concurrent Expression Of MYC/BCL2 Protein In Newly Diagnosed DLBCL Is Not Associated With An Inferior Survival Following EPOCH-R Therapy

DNA Sequencing-Based Monitoring Of Serum Predicts Clinical Relapse Before CT Imaging in Diffuse Large B-Cell Lymphoma

Study On The Fertility Status Of Females With Primary Mediastinal B-Cell Lymphoma Following Treatment With Dose-Adjusted EPOCH-Rituximab

DA-EPOCH Chemotherapy Is Highly Effective in ALK-Positive and ALK-Negative ALCL: Results of a Prospective Study of PTCL Subtypes in Adults

Rituximab Is Associated with Prolonged Immunoglobulin Deficiency In Newly Diagnosed Patients with Aggressive B-Cell Lymphoma Receiving Immunochemotherapy

Comparative Clinical and Biological Features of Primary Mediastinal B-Cell Lymphoma (PMBL) and Mediastinal Grey Zone Lymphoma (MGZL).

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

Gray Zone Lymphomas: Clinical and Histological Characteristics and Treatment with Dose-Adjusted-EPOCH-R

A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Refractory or Relapsed Lymphoid Malignancies.

Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome May Be Significantly Improved by the Addition of Rituximab to Dose-Adjusted (DA)-EPOCH and Obviates the Need for Radiation: Results from a Prospective Study of 44 Patients.

DA-EPOCH-R Is Highly Effective in Both BCL-6+ and BCL-6− Untreated De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Study Update and Analysis of Survival Outcomes for Multiple Biomarkers.

Novel Treatment of Burkitt Lymphoma with Dose-Adjusted EPOCH-Rituximab: Preliminary Results Showing Excellent Outcome.

A Pilot Trial of Campath-1H and Dose-Adjusted EPOCH in CD52-Expressing Aggressive T-Cell Malignancies.

Phase I/II study of Bortezomib Alone and Bortezomib with Dose-Adjusted EPOCH Chemotherapy in Relapsed or Refractory Aggressive B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only